Bharat Bio working on nasal vaccine

Last Updated on December 11, 2020 by The Health Master

Bharat Biotech is expected to initiate Phase-1 trials of its intranasal vaccine for C-19 next month, chairman and MD Krishna Ella said on Tuesday.

He said his firm is setting up two more facilities for manufacturing vaccines, including for Covaxin. “I think it will enter into Phase 1 (next month) because it is going to be a single dose vaccine.”

• Action against sale of habit-forming drugs without prescription: Tamil Nadu
• Gujarat’s Medical Device Park: A Game-Changer for India’s Healthcare Sector
• Key Notes on Revised Schedule M: Point No. 8 – Change Control
• Drug recall: Aurobindo Pharma, Glenmark, Zydus recall Drugs
• Hospitals can’t force Patients to buy medicines from their in house Medical Store
• FDA Haryana Organizes Workshop for Chemists: Yamunanagar

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram..